Antoni Ribas, MD, PhD | Authors


Sequencing Agents for the Treatment of Patients With Melanoma

June 22, 2016

Antoni Ribas, MD, PhD, professor of Hematology and Oncology and director of the Tumor Immunology Program Area at UCLA Jonsson Comprehensive Cancer Center, discusses how to appropriately sequence therapies for patients with melanoma.

The Excitement Surrounding Immunotherapies for Melanoma

March 04, 2014

Antoni Ribas, MD, PhD, professor of medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, discusses the excitement surrounding immunotherapies for the treatment of patients with melanoma.